#AHA20 – A small phase 2 randomized trial showed significantly improved survival with an early ECMO-facilitated resuscitation for patients with out-of-hospital cardiac arrest and refractory ventricular fibrillation

Advanced reperfusion strategies for patients with out-of-hospital cardiac arrest and refractory ventricular fibrillation (ARREST): a phase 2, single centre, open-label, randomised controlled trial – The Lancet

Commentaries: Early ECMO-Facilitated Resuscitation for Out-of-Hospital Cardiac Arrest – NEJM Journal Watch AND Advanced REperfusion STrategies for refractory cardiac arrest – ARREST – American College of Cardiology AND Cardiac arrest treatment that uses life support machine boosts survival – NIH News Releases

Commentary on Twitter

Latebreaker at #AHA20 @AHAMeetings—Advanced reperfusion strategies for patients with out-of-hospital #cardiacarrest and refractory ventricular fibrillation (ARREST): a phase 2, single centre, open-label, randomised controlled trialhttps://t.co/1TjdlD6G8h pic.twitter.com/zQoRcxF1jO

— The Lancet (@TheLancet) November 14, 2020